开发并心理测量学验证用于评估类风湿关节炎与中轴型脊柱关节炎患者恐惧的患者报告结局工具:炎症性风湿病恐惧评估(FAIR)问卷
在672例类风湿关节炎(432例)和中轴型脊柱关节炎(240例)患者中开发并验证FAIR问卷,最终10个条目内部一致性高(Cronbach's α=0.89)且为单维度;高恐惧评分占17.2%,与高无助感、焦虑、抑郁、低教育水平及高感知疾病活动度相关。
要点
- FAIR问卷共10个条目,Cronbach's α=0.89,单维度结构。
- 类风湿关节炎患者平均恐惧评分51.2(±25.4),中轴型脊柱关节炎60.5(±22.9)。
- 高恐惧评分占17.2%,与心理困扰及高感知疾病活动度相关。
核心结论
- 总体17.2%的患者高恐惧评分,尽管疾病常控制良好。
- 高恐惧评分与心理困扰相关。
- 该问卷在常规实践和临床试验中可能有用。
研究设计与样本
- 横断面验证研究,纳入诊断为类风湿关节炎或中轴型脊柱关节炎的患者。
- 恐惧来自定性研究并改写为0-10数字评分量表同意度的陈述句。
- 排除相关性>0.65的冗余条目,评估内部一致性(Cronbach's α)和因子结构(主成分分析)。
- 用聚类分析将患者分为恐惧等级,用多元逻辑回归评估患者变量与恐惧等级的关联。
主要发现
- 验证研究共纳入672例患者(类风湿关节炎432例,中轴型脊柱关节炎240例),多数为中度疾病活动度并处方生物制剂。
- 最终问卷含10个问题,内部一致性高(α=0.89),为单维度。
- 平均评分(±SD)类风湿关节炎为51.2(±25.4),中轴型脊柱关节炎为60.5(±22.9)。
- 识别出高恐惧评分组17.2%、中恐惧评分组41.1%和低恐惧评分组41.7%。
- 高恐惧评分与高关节炎无助感指数评分(OR 6.85,95%CI 3.95至11.87)、高医院焦虑抑郁量表焦虑评分(OR 5.80,95%CI 1.19至4.22)和抑郁评分(OR 2.37,95%CI 1.29至4.37)、低教育水平(OR 3.48,95%CI 1.37至8.83)及高感知疾病活动度(OR 2.36,95%CI 1.10至5.04)相关。
关键数值与推荐
- 最终问卷含10个条目,Cronbach's α=0.89,单维度。
- 高恐惧评分组占17.2%,中恐惧评分组占41.1%,低恐惧评分组占41.7%。
- 高恐惧评分与高关节炎无助感指数评分相关(OR 6.85,95%CI 3.95至11.87)。
- 高恐惧评分与高医院焦虑抑郁量表焦虑评分相关(OR 5.80,95%CI 1.19至4.22)和抑郁评分相关(OR 2.37,95%CI 1.29至4.37)。
- 高恐惧评分与低教育水平相关(OR 3.48,95%CI 1.37至8.83)及高感知疾病活动度相关(OR 2.36,95%CI 1.10至5.04)。
临床怎么用
- 作者认为该问卷在常规实践和临床试验中可能有用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop and validate an outcome measure for assessing fears in patients with rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA). METHODS: Fears were identified in a qualitative study, and reformulated as assertions with which participants could rate their agreement (on a 0-10 numeric rating scale). A cross-sectional validation study was performed including patients diagnosed with RA or axSpA. Redundant items (correlation >0.65) were excluded. Internal consistency (Cronbach's α) and factorial structure (principal component analysis) were assessed. Patients were classified into fear levels (cluster analysis). Associations between patient variables and fear levels were evaluated using multiple logistic regression. RESULTS: 672 patients were included in the validation study (432 RA, 240 axSpA); most had moderate disease activity and were prescribed biologics. The final questionnaire included 10 questions with high internal consistency (α: 0.89) and a single dimension. Mean scores (±SD) were 51.2 (±25.4) in RA and 60.5 (±22.9) in axSpA. Groups of patients with high (17.2%), moderate (41.1%) and low (41.7%) fear scores were identified. High fear scores were associated with high Arthritis Helplessness Index scores (OR 6.85, 95% CI (3.95 to 11.87)); high Hospital Anxiety and Depression Scale anxiety (OR 5.80, 95% CI (1.19 to 4.22)) and depression (OR 2.37, 95% CI (1.29 to 4.37)) scores; low education level (OR 3.48, 95% CI (1.37 to 8.83)); and high perceived disease activity (OR 2.36, 95% CI (1.10 to 5.04)). CONCLUSIONS: Overall, 17.2% of patients had high fear scores, although disease was often well controlled. High fear scores were associated with psychological distress. This questionnaire could be useful both in routine practice and clinical trials.
引用
- Gossec L, Chauvin P, Saraux A, et al. Development and psychometric validation of a patient-reported outcome measure to assess fears in rheumatoid arthritis and axial spondyloarthritis: the Fear Assessment in Inflammatory Rheumatic diseases (FAIR) questionnaire. Ann Rheum Dis. 2017. PMID: 29102955. doi:10.1136/annrheumdis-2017-212000
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。